MEDIAN TECHNOLOGIES
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.
MEDIAN TECHNOLOGIES
Industry:
Clinical Trials Health Care Pharmaceutical
Founded:
2002-01-01
Address:
Valbonne, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.mediantechnologies.com
Total Employee:
101+
Status:
Active
Contact:
+330493333777
Email Addresses:
[email protected]
Total Funding:
122.89 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
BC Platforms
BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
myTomorrows
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
Parnell Living Science
Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Median Technologies
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Median Technologies
Abingworth
Abingworth investment in Post-IPO Equity - Median Technologies
Omega Funds
Omega Funds investment in Post-IPO Equity - Median Technologies
Abingworth
Abingworth investment in Post-IPO Equity - Median Technologies
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Median Technologies
Idinvest Partners
Idinvest Partners investment in Post-IPO Equity - Median Technologies
Threshold
Threshold investment in Post-IPO Equity - Median Technologies
Auriga Partners
Auriga Partners investment in Post-IPO Equity - Median Technologies
Omega Funds
Omega Funds investment in Post-IPO Equity - Median Technologies
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-29 | Median Technologies Appoints Jean-Christophe Montigny as Chief Financial Officer and Member of the Executive Committee |
Official Site Inspections
http://www.mediantechnologies.com Semrush global rank: 4.77 M Semrush visits lastest month: 1.93 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Median Technologies"
Home - Median Technologies
Nov 7, 2024 · We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical …See details»
About us - Median Technologies
We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs. With eyonis™ we are disrupting the …See details»
Investors - Median Technologies
We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs. With eyonis™ we are disrupting the …See details»
Median Technologies - Crunchbase Company Profile
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, screening, and clinical practice. View contacts for Median Technologies to access new leads and connect with …See details»
Median Technologies - LinkedIn
Our iCRO solutions for medical image analysis and management in oncology trials and eyonis™, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and...See details»
Median Technologies Inc - MassBio
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone.See details»
Median Technologies Reports Its Business Activity for the First Half …
Jul 12, 2023 · Median Technologies (Euronext Growth - ALMDT) reports today its business indicators for the first half of 2023 for the iCRO activity (non-audited figures) and the iBiopsy® …See details»
Median Technologies' Business Continues to Grow at a Steady …
Jul 8, 2021 · Median Technologies (Paris:ALMDT) (ALMDT) today announces strong business growth for the first half of 2021 (unaudited figures). For the first half of 2021, Median …See details»
Median Technologies Reports 2024 Q3 Operational and Financial …
Oct 24, 2024 · The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the …See details»
Median Technologies Reports Full-Year 2021 Results and Business ...
Apr 21, 2022 · Median Technologies (Euronext Growth - ALMDT) (Paris:ALMDT) whose Board of Directors met on April 20, 2022 to close the consolidated financial statements for the year …See details»
Median Technologies - Overview, News & Similar companies
Jan 25, 2024 · Median Technologies contact info: Phone number: +33 493333777 Website: www.mediantechnologies.com What does Median Technologies do? Median Technologies …See details»
Median Technologies Reports 2024 Q3 Operational and
Oct 24, 2024 · Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered …See details»
MEDIAN Technologies - Craft
Oct 22, 2024 · MEDIAN Technologies has 5 employees across 3 locations and €22.23 m in annual revenue in FY 2023. See insights on MEDIAN Technologies including office locations, …See details»
Median Technologies Initial Public offering on Euronext
Nov 15, 2024 · Median Technologies offers innovative imaging solutions and services to improve healthcare for all. The group uses the power of phenomic imaging to contribute to the …See details»
Median Technologies reports full-year 2023 financial results and ...
Apr 25, 2024 · Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”) today reported its 2023 consolidated annual financial results, as …See details»
Median Technologies - Overview, News & Similar companies
Apr 25, 2024 · View Median Technologies (www.mediantechnologies.com) location in Provence-Alpes-Cote d'Azur, France , revenue, industry and description. Find related and similar …See details»
Median Technologies reports 2023 revenue and summarizes 2024 …
Jan 29, 2024 · Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces its 2023 revenue, outlining both its strategic outlook and key milestones for 2024.See details»
Median Technologies Announces 2021 Revenue of €20.5 Million, …
Jan 17, 2022 · Median Technologies develops new AI-based Software as a Medical Device (SaMD) for early diagnosis of cancer and metabolic diseases. The company’s goal is to …See details»
Median Technologies reports full-year 2021 results and business ...
Apr 21, 2022 · Sophia Antipolis, France – Median Technologies (Euronext Growth - ALMDT) whose Board of Directors met on April 20, 2022 to close the consolidated financial statements …See details»
Median Technologies Announces Its 2022 Half-year ... - Business …
Oct 20, 2022 · Median is positioning itself to become the strategic partner to extract insights from medical images by applying AI solutions to better understand the mechanism of action of new …See details»